EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-2.54%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$969M
AUM Growth
+$969M
(-26%)
Cap. Flow
-$232M
Cap. Flow
% of AUM
-23.92%
Top 10 Holdings %
Top 10 Hldgs %
64.29%
Holding
82
New
14
Increased
14
Reduced
29
Closed
17
Top Buys
| 1 |
HCA Healthcare
HCA
|
$14M |
| 2 |
Bruker
BRKR
|
$13.8M |
| 3 |
Edwards Lifesciences
EW
|
$12.6M |
| 4 |
DexCom
DXCM
|
$11.6M |
| 5 |
Teleflex
TFX
|
$11M |
Top Sells
| 1 |
Insmed
INSM
|
$79.5M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$49.7M |
| 3 |
United Therapeutics
UTHR
|
$30.8M |
| 4 |
Bio-Techne
TECH
|
$26.2M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$21.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arcutis Biotherapeutics
ARQT
$1.86B
| $2.66M | 0.24% | 191,158 -502,105 | -72% | -$6.99M |
|
52
Dentsply Sirona
XRAY
$2.85B
| $2.65M | 0.24% | +139,656 | New | +$2.65M |
|
53
Xoma
XOMA
$392M
| $2.51M | 0.22% | 95,417 +1,128 | +1% | +$29.6K |
|
54
iTeos Therapeutics
ITOS
| $1.69M | 0.15% | +220,196 | New | +$1.69M |
|
55
Karyopharm Therapeutics
KPTI
$61.7M
| $1.41M | 0.13% | 2,088,757 -3,459,123 | -62% | -$2.34M |
|
|
ZBIO
56
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $1.41M | 0.13% | 172,103 -18,428 | -10% | -$151K |
|
57
Sutro Biopharma
STRO
$72.7M
| $1.28M | 0.11% | 694,408 -1,147,581 | -62% | -$2.11M |
|
58
InflaRx
IFRX
$108M
| $1.22M | 0.11% | 492,452 -1,129,335 | -70% | -$2.79M |
|
|
AMRN
59
Amarin Corp
AMRN
$311M
| $736K | 0.07% | 1,516,592 -1,792,717 | -54% | -$869K |
|
60
Absci
ABSI
$357M
| $523K | 0.05% | 199,464 -73,405 | -27% | -$192K |
|
61
Alector
ALEC
$238M
| $378K | 0.03% | 200,095 -132,661 | -40% | -$251K |
|
|
AUTL
62
Autolus Therapeutics
AUTL
$399M
| $232K | 0.02% | 98,895 -307,663 | -76% | -$723K |
|
63
AC Immune
ACIU
$205M
| – | – | -99,313 | Closed | -$375K |
|
|
AFMD
64
DELISTED
Affimed
AFMD
| – | – | -166,460 | Closed | -$559K |
|
|
JBIO
65
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| – | – | -485,141 | Closed | -$1.01M |
|
66
Bausch Health
BHC
$2.74B
| – | – | -1,530,914 | Closed | -$12.5M |
|
67
Biohaven
BHVN
$1.63B
| – | – | -132,537 | Closed | -$6.62M |
|
68
Brookdale Senior Living
BKD
$1.83B
| – | – | -861,268 | Closed | -$5.85M |
|
|
69
Insmed
INSM
$28.8B
| – | – | -1,089,404 | Closed | -$79.5M |
|
70
IQVIA
IQV
$32.4B
| – | – | -13,138 | Closed | -$3.11M |
|
71
Kura Oncology
KURA
$686M
| – | – | -192,398 | Closed | -$3.76M |
|
72
Molina Healthcare
MOH
$9.8B
| – | – | -10,588 | Closed | -$3.65M |
|
73
Maravai LifeSciences
MRVI
$350M
| – | – | -336,966 | Closed | -$2.8M |
|
74
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
75
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|